Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shengyu Yang

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Cancer Research|November 12, 2014
LASP1 is a HIF1α target gene critical for metastasis of pancreatic cancerTiansuo Zhao, He Ren, Jing Li, et al.
Gut|March 6, 2021
ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4Tianxing Zhou, Jing Liu, Yongjie Xie, et al.
Signal Transduction and Targeted Therapy|July 13, 2023
BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesisChongbiao Huang, Hui Li, Yang Xu, et al.
Cancer Research|April 12, 2022
Mitochondrial Calcium Uniporter Drives Metastasis and Confers a Targetable Cystine Dependency in Pancreatic CancerXiuchao Wang, Yunzhan Li, Zekun Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 21, 2026
Mitochondrial Calcium Uniporter Drives Chemoresistance in Pancreatic Cancer via Glutathione-Mediated Stemness MaintenanceZekun Li, Chenyang Meng, Guangcong Shen, et al.
Journal of Clinical Immunology|April 14, 2011
Lack of association between ORAI1/CRACM1 gene polymorphisms and Kawasaki disease in the Taiwanese childrenHo-Chang Kuo, Ying-Jui Lin, Suh-Hang Hank Juo, et al.
The Journal of Experimental Medicine|February 9, 2019
Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinomaJing Liu, Wenna Jiang, Kaili Zhao, et al.
Science Advances|June 19, 2024
BICC1 drives pancreatic cancer stemness and chemoresistance by facilitating tryptophan metabolismHuizhi Sun, Hui Li, Yuqi Guan, et al.
Gastroenterology|March 16, 2024
Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2<sup>+</sup> Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and ImmunotherapyYongjie Xie, Tianxing Zhou, Xueyang Li, et al.
Cancer Biology & Medicine|June 29, 2023
Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinomaDanqi Fu, Jingrui Yan, Zhaoyu Zhang, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Cancer Research|November 12, 2014
LASP1 is a HIF1α target gene critical for metastasis of pancreatic cancerTiansuo Zhao, He Ren, Jing Li, et al.
Gut|March 6, 2021
ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4Tianxing Zhou, Jing Liu, Yongjie Xie, et al.
Signal Transduction and Targeted Therapy|July 13, 2023
BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesisChongbiao Huang, Hui Li, Yang Xu, et al.
Cancer Research|April 12, 2022
Mitochondrial Calcium Uniporter Drives Metastasis and Confers a Targetable Cystine Dependency in Pancreatic CancerXiuchao Wang, Yunzhan Li, Zekun Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 21, 2026
Mitochondrial Calcium Uniporter Drives Chemoresistance in Pancreatic Cancer via Glutathione-Mediated Stemness MaintenanceZekun Li, Chenyang Meng, Guangcong Shen, et al.
Journal of Clinical Immunology|April 14, 2011
Lack of association between ORAI1/CRACM1 gene polymorphisms and Kawasaki disease in the Taiwanese childrenHo-Chang Kuo, Ying-Jui Lin, Suh-Hang Hank Juo, et al.
The Journal of Experimental Medicine|February 9, 2019
Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinomaJing Liu, Wenna Jiang, Kaili Zhao, et al.
Science Advances|June 19, 2024
BICC1 drives pancreatic cancer stemness and chemoresistance by facilitating tryptophan metabolismHuizhi Sun, Hui Li, Yuqi Guan, et al.
Gastroenterology|March 16, 2024
Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2<sup>+</sup> Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and ImmunotherapyYongjie Xie, Tianxing Zhou, Xueyang Li, et al.
Cancer Biology & Medicine|June 29, 2023
Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinomaDanqi Fu, Jingrui Yan, Zhaoyu Zhang, et al.
Pageof 9